Literature DB >> 19728029

CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients.

Elisabet Björklund1, Astrid Gruber2, Joanna Mazur3, Anna Mårtensson4,5, Mona Hansson4, Anna Porwit6.   

Abstract

Fast development in polychromatic flow cytometry (PFC) makes it possible to study CD34+ cells with two scatter and eight fluorescence parameters. Minimal residual disease (MRD) is determined as persistence of leukemic cells at submicroscopic levels in bone marrow (BM) of patients in complete remission. MRD can be present in collections of hematopoietic stem cell from blood (HSC-B). Using PFC, we have defined patterns of antigen expression in CD34+ cell subpopulations in BM and applied them as templates in MRD analysis. Twelve BM samples from hospital control (HC) patients with no signs of hematological malignancy were studied using five 8-color monoclonal antibody combinations detecting subsets of CD34+ cells. These patterns have been used as templates to determine levels of MRD in HSC-B collections from six AML patients. Several subsets of CD34+ precursor cells were found to be present at very low frequencies (<10(-4)) in BM and/or HSC-B collections. All six HSC-B collections from AML patients showed MRD by 8-color technique and only three by previously applied 3-color method. The 8-color technique showed promising results in efficient detection of different CD34+ subpopulations of HSC-B and in MRD quantification. Monitoring of MRD should become a part of quality control of HSC-B collections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728029     DOI: 10.1007/s12185-009-0389-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  41 in total

Review 1.  Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells.

Authors:  P Menéndez; M C del Cañizo; A Orfao
Journal:  J Biol Regul Homeost Agents       Date:  2001 Jan-Mar       Impact factor: 1.711

2.  Identification of a novel, human multilymphoid progenitor in cord blood.

Authors:  Q L Hao; J Zhu; M A Price; K J Payne; L W Barsky; G M Crooks
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

3.  Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia.

Authors:  A Venditti; F Buccisano; G Del Poeta; L Maurillo; A Tamburini; C Cox; A Battaglia; G Catalano; B Del Moro; L Cudillo; M Postorino; M Masi; S Amadori
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

4.  Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia.

Authors:  A Reichle; G Rothe; S Krause; M Zaiss; H Ullrich; G Schmitz; R Andreesen
Journal:  Leukemia       Date:  1999-08       Impact factor: 11.528

5.  Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection.

Authors:  T Inaba; C Shimazaki; T Hirata; E Ashihara; K Okawa; N Oku; H Goto; N Fujita; H Tsuji; M Nakagawa
Journal:  Bone Marrow Transplant       Date:  1994-05       Impact factor: 5.483

6.  Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors.

Authors:  L Perey; R Peters; S Pampallona; P Schneider; N Gross; S Leyvraz
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

7.  Flow cytometric analysis of hemetopoietic progenitor cells in peripheral blood stem cell harvest from patients with CD34 positive acute leukemia.

Authors:  T Miyazaki; I Matsuda; M Oguri; H Amaya; M Kiyosaki; A Hamada; S Tamaki; E Tashiro; Y Kudo; O Taniguchi; T Nakamura; S Tomoyasu
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

8.  MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.

Authors:  N Feller; M A van der Pol; A van Stijn; G W D Weijers; A H Westra; B W Evertse; G J Ossenkoppele; G J Schuurhuis
Journal:  Leukemia       Date:  2004-08       Impact factor: 11.528

9.  Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.

Authors:  T Seriu; S Yokota; M Nakao; S Misawa; Y Takaue; S Koizumi; S Kawai; T Fujimoto
Journal:  Leukemia       Date:  1995-04       Impact factor: 11.528

10.  Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.

Authors:  G E Tjønnfjord; R Steen; S A Evensen; E Thorsby; T Egeland
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

View more
  2 in total

1.  Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.

Authors:  Tomohisa Yamashita; Sarfaraz Ahmad; Kendra N Wright; Drew J Roberts; Jessica L VonCannon; Hao Wang; Leanne Groban; Louis J Dell'Italia; Carlos M Ferrario
Journal:  Hypertension       Date:  2019-12-09       Impact factor: 10.190

2.  Universal monitoring of minimal residual disease in acute myeloid leukemia.

Authors:  Elaine Coustan-Smith; Guangchun Song; Sheila Shurtleff; Allen Eng-Juh Yeoh; Wee Joo Chng; Siew Peng Chen; Jeffrey E Rubnitz; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  JCI Insight       Date:  2018-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.